IDH1 and glioma: For example, previous research using data from The Cancer Genome Atlas and The Cancer Imaging Archive produced similar results, namely that a lack of enhancement predicted longer progression-free survival in lower grade gliomas after accounting for IDH1 and 1p/19q status, while a smooth non-enhancing margin correlated with better progression-free and overall survival [28].